CurrentRheuma
Get Weekly

Topic · page 6 of 17

Systemic sclerosis & Raynaud's

Limited and diffuse systemic sclerosis, skin, lung (interstitial lung disease), pulmonary arterial hypertension, heart, gut and kidney involvement in systemic sclerosis, digital ulcers, primary and secondary Raynaud's phenomenon, very early systemic sclerosis

Briefs 201–240 of 671 placed here, newest publication first

Briefs in Systemic sclerosis & Raynaud's

Newest publication first

  1. Semin Arthritis Rheum

    Raynaud’s phenomenon is associated with an increased risk of cardiovascular disease and venous thromboembolism

    Cohort study

  2. Clin Exp Rheumatol

    Hopelessness is associated to severity of both digital vasculopathy and lung disease in systemic sclerosis patients: a prospective one-year study

    Cohort study

  3. Clin Exp Rheumatol

    Evaluation of different algorithms to identify the scleroderma pattern in nailfold videocapillaroscopy

    Diagnostic or prognostic study

  4. Clin Exp Rheumatol

    Impact of immunosuppression on development and outcome of systemic sclerosis-associated pulmonary arterial hypertension

    Cohort study

  5. Clin Exp Rheumatol

    Risk factors of cognitive function impairment in patients with systemic sclerosis

    Cohort study

  6. Rheumatology (Oxford)

    Emphysema elevates the DETECT scores: impact on pulmonary hypertension screening and diagnosis in systemic sclerosis

    Cohort study

  7. Rheumatology (Oxford)

    Unveiling the clinical spectrum of ACA-positive SSC-ILD: not as benign as expected

    Cross-sectional study

  8. Arthritis Rheumatol

    Peripheral Blood Gene Expression Profiling and Prognostic Significance for the Course of Interstitial Lung Disease in Patients With Systemic Sclerosis

    Secondary analysis

  9. Arthritis Res Ther

    Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale)

    Cross-sectional study

  10. Semin Arthritis Rheum

    The role of surgery in esophageal involvement in systemic sclerosis: A systematic literature review

    Research article

  11. Arthritis Rheumatol

    Hand Swelling and Other Non–Raynaud Phenomenon Symptoms as the Initial Presentation of Systemic Sclerosis: Prevalence and Clinical Associations in Two US Cohorts

    Cohort study

  12. Rheumatology (Oxford)

    Anti-RNA polymerase III antibodies in systemic sclerosis: prevalence and clinical associations from a systematic review and meta-analysis

    Meta-analysis

  13. RMD Open

    Value of the 6 min walk test in detecting cardiopulmonary involvement in patients with systemic sclerosis

    Cohort study

  14. Rheumatology (Oxford)

    Thermographic abnormalities associate with electrocardiogram/echocardiographic changes and mortality in systemic sclerosis: a retrospective cohort study

    Cohort study

  15. Rheumatology (Oxford)

    Anti-cytolethal distending toxin antibodies in systemic sclerosis: associations with gastrointestinal disease and immune dysregulation

    Cross-sectional study

  16. Arthritis Res Ther

    Identification of serum exosome proteins in systemic sclerosis with interstitial lung disease by aptamer proteomics

    Mechanistic study

  17. RMD Open

    Differences in nailfold capillaroscopy findings between limited and diffuse cutaneous systemic sclerosis: a detailed analysis

    Cross-sectional study

  18. Rheumatology (Oxford)

    Prognostic value of baseline nailfold videocapillaroscopy in predicting pulmonary decline and disease progression in SSc

    Cohort study

  19. Ann Rheum Dis

    Spatially informed phenotyping by cyclic-in-situ-hybridisation identifies novel fibroblast populations and their pathogenic niches in systemic sclerosis

    Mechanistic study

  20. Arthritis Care Res (Hoboken)

    Avoidant or Restrictive Food Intake Disorder Symptoms in Adults With Systemic Sclerosis: A Nationwide Study in Spain

    Cross-sectional study

  21. Ann Rheum Dis

    Antimitochondrial antibodies in systemic sclerosis target enteric neurons and are associated with GI dysmotility

    Cross-sectional study

  22. RMD Open

    Computed tomography-derived quantitative imaging biomarkers enable the prediction of disease manifestations and survival in patients with systemic sclerosis

    Cohort study

  23. Joint Bone Spine

    Quantitative HRCT as a surrogate outcome measure for nintedanib treatment in systemic sclerosis-interstitial lung disease and idiopathic pulmonary fibrosis

    Cohort study

  24. Rheumatology (Oxford)

    Distribution of white matter hyperintensity in SSc patients: a monocenter, cross-sectional magnetic resonance imaging study

    Cross-sectional study

  25. Arthritis Care Res (Hoboken)

    Validation of Lung Ultrasound Interpretation Criteria for Interstitial Lung Disease in Systemic Sclerosis and Inflammatory Myopathy

    Diagnostic or prognostic study

  26. Ann Rheum Dis

    Integrative exome sequencing and machine learning identify MICB and interferon pathway genes as contributors to SSc risk

    Cohort study

  27. Rheumatology (Oxford)

    Comparison of quantitative lung ultrasound scores with automated quantitative CT: to overcome the ultrasound limitations

    Cross-sectional study

  28. RMD Open

    Combination therapy of rituximab and mycophenolate in patients with systemic sclerosis and primary cardiac involvement refractory to cyclophosphamide: a retrospective exploratory analysis of 10 cases

    Cohort study

  29. Rheumatology (Oxford)

    Targeting PTGDS inhibits pro-inflammatory fibroblasts associated with skin fibrosis in systemic sclerosis

    Mechanistic study

  30. Semin Arthritis Rheum

    Comparing Raynaud’s phenomenon attack measurement tools: paper or smartphone application?

    Randomized controlled trial

  31. Rheumatology (Oxford)

    Frequency-specific microcurrent improves hand function and Raynaud’s symptoms in scleroderma: results of two pilot studies

    Research article

  32. Rheumatology (Oxford)

    Long-term effects of selexipag in SSc-associated digital ulcers: a case-control multicentre observational study

    Case-control study

  33. Arthritis Res Ther

    Artificial intelligence-based Raynaud’s quantification index (ARTIX): an objective mobile-based tool for patient-centered assessment of Raynaud’s phenomenon

    Diagnostic or prognostic study

  34. Rheumatology (Oxford)

    Lung function and skin fibrosis changes as predictors of survival in SSc-associated interstitial lung disease: a EUSTAR study

    Cohort study

  35. Rheumatology (Oxford)

    Temporal trends in vascular medication use in 8079 patients with systemic sclerosis: insights to inform future trials and therapeutic strategies from the EUSTAR cohort

    Cross-sectional study

  36. Rheumatology (Oxford)

    Predicting trajectories of lung function decline in systemic sclerosis–related interstitial lung disease

    Cohort study

  37. Arthritis Res Ther

    Serum IL-40 is elevated in systemic sclerosis and is linked to disease activity, gastrointestinal involvement, immune regulation and fibrotic processes

    Cross-sectional study

  38. Rheumatology (Oxford)

    Cardiovascular and venous thromboembolic events in systemic sclerosis: epidemiological analysis of the Clinical Practice Research Datalink

    Cohort study

  39. Rheumatology (Oxford)

    An exploratory trial of a single dose of CAM2043 (treprostinil subcutaneous depot) in SSc-related RP

    Secondary analysis

  40. Clin Exp Rheumatol

    Risk of major cardiovascular events in patients with systemic sclerosis: insights into an underestimated concern from a systematic literature review and meta-analysis

    Meta-analysis

All 671 Briefs in ExploreShowing Briefs 201–240 of 671, newest first